ALA-induced PpIX fluorescence in epileptogenic tissue

Astrogliotic tissue displays markedly increased levels of ALA-induced PpIX fluorescence, making it useful for fluorescence-guided resection in glioma surgery. In patients with temporal lobe epilepsy (TLE) and corresponding animal models, there are areas of astrogliosis that often co-localize with the epileptic focus, which can be resected to eliminate seizures in the majority of treated patients. If this epileptogenic tissue can exhibit PpIX fluorescence that is sufficiently localized, it could potentially help identify margins in epilepsy surgery. We tested the hypothesis that ALA-induced PpIX fluorescence could visually accentuate epileptogenic tissue, using an established animal model of chronic TLE. An acute dose of pilocarpine was used to induce chronic seizure activity in a rat. This rat and a normal control were given ALA, euthanized, and brains examined post-mortem for PpIX fluorescence and neuropathology. Preliminary evidence indicates increased PpIX fluorescence in areas associated with chronic epileptic changes and seizure generation in TLE, including the hippocampus and parahippocampal areas. In addition, strong PpIX fluorescence was clearly observed in layer II of the piriform cortex, a region known for epileptic reorganization and involvement in the generation of seizures in animal studies. We are further investigating whether ALA-induced PpIX fluorescence can consistently identify epileptogenic zones, which could warrant the extension of this technique to clinical studies for use as an adjuvant guidance technology in the resection of epileptic tissue.

[1]  Dieter Schmidt,et al.  Long‐term seizure outcome of surgery versus no surgery for drug‐resistant partial epilepsy: A review of controlled studies , 2009, Epilepsia.

[2]  M. Holmes Dense array EEG: Methodology and new hypothesis on epilepsy syndromes , 2008, Epilepsia.

[3]  H. Vinters,et al.  Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome , 2009, Neurology.

[4]  I. Fried,et al.  Anatomic temporal lobe resections for temporal lobe epilepsy. , 1993, Neurosurgery clinics of North America.

[5]  W T Blume,et al.  A randomized, controlled trial of surgery for temporal-lobe epilepsy. , 2001, The New England journal of medicine.

[6]  O. Wiestler,et al.  Ammon's Horn Sclerosis: A Maldevelopmental Disorder Associated with Temporal Lobe Epilepsy , 2002, Brain pathology.

[7]  O Ganslandt,et al.  Neuronavigation: concept, techniques and applications. , 2002, Neurology India.

[8]  Garnette R Sutherland,et al.  Optimizing Epilepsy Surgery with Intraoperative MR Imaging , 2002, Epilepsia.

[9]  C E Elger,et al.  Preoperative Evaluation for Epilepsy Surgery (Bonn Algorithm) , 2002, Zentralblatt fur Neurochirurgie.

[10]  Maria Thom,et al.  Temporal Lobe Sclerosis Associated With Hippocampal Sclerosis in Temporal Lobe Epilepsy: Neuropathological Features , 2009, Journal of neuropathology and experimental neurology.

[11]  D A Pollen,et al.  Neuroglia: Gliosis and Focal Epilepsy , 1970, Science.

[12]  Johan Moan,et al.  On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. , 2004, Current medicinal chemistry. Anti-cancer agents.

[13]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[14]  Keith D. Paulsen,et al.  Estimation of Brain Deformation for Volumetric Image Updating in Protoporphyrin IX Fluorescence-Guided Resection , 2009, Stereotactic and Functional Neurosurgery.

[15]  Luiz E A M Mello,et al.  Characterization of Reactive Astrocytes in the Chronic Phase of the Pilocarpine Model of Epilepsy , 2002, Epilepsia.

[16]  E. Cavalheiro,et al.  Seizures produced by pilocarpine: Neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain , 1986, Brain Research.

[17]  O. Carter Snead,et al.  Surgical treatment of medically refractory epilepsy in childhood , 2001, Brain and Development.

[18]  A. Kivi,et al.  Alterations of Glial Cell Function in Temporal Lobe Epilepsy , 2000, Epilepsia.

[19]  G. Pastores,et al.  7 Pathological features , 1997 .

[20]  P. F. Fabene,et al.  Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat , 2006, Brain Research Bulletin.

[21]  Xiaoyao Fan,et al.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.

[22]  J. Helen Cross,et al.  Epilepsy Surgery in Childhood , 2002 .

[23]  Hui-Kuo Shu,et al.  Metastasis infiltration: an investigation of the postoperative brain-tumor interface. , 2011, International journal of radiation oncology, biology, physics.

[24]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[25]  R D Johnson,et al.  The impact of new imaging technologies in neurosurgery. , 2008, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[26]  Christopher Nimsky,et al.  Non‐invasive detection of hippocampal sclerosis: correlation between metabolite alterations detected by 1H‐MRS and neuropathology , 2008, NMR in biomedicine.

[27]  Joseph I Sirven,et al.  An overview of surgery for chronic seizures. , 2003, Mayo Clinic proceedings.

[28]  Ernst Fernando Lopes Da Silva Niedermeyer,et al.  Electroencephalography, basic principles, clinical applications, and related fields , 1982 .

[29]  Brian W Pogue,et al.  Review of Neurosurgical Fluorescence Imaging Methodologies , 2010, IEEE Journal of Selected Topics in Quantum Electronics.

[30]  Otto Muzik,et al.  Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? , 2000, Annals of neurology.